Drug therapy of sexually transmitted diseases

CHAPTER 95


Drug therapy of sexually transmitted diseases


Sexually transmitted diseases (STDs), also known as sexually transmitted infections, are infectious diseases transmitted primarily through sexual contact. STDs are very common in the United States and constitute a major public health problem. In 2009, the Centers for Disease Control and Prevention (CDC) received more than 1.5 million reports of STDs, including 1,244,180 cases of genital Chlamydia trachomatis infection, 301,174 cases of gonorrhea, and 13,997 cases of syphilis. However, because most STDs go unreported, the actual incidence is much higher, estimated at 19 million new infections a year, 50% of which occur in people under the age of 25. According to the CDC, Americans now have a 25% lifetime risk of contracting an STD.


Our objective in this chapter is to describe the principal STDs and provide an overview of their treatment. Table 95–1 presents a summary of the common STDs, causative organisms, and drugs of choice for treatment. The basic pharmacology of these drugs is discussed in other chapters.



TABLE 95–1 


Drug Therapy of Sexually Transmitted Diseases*











































































































































































































Disease or Syndrome Recommended Treatment Causative Organism(s)
Chlamydia trachomatis Infections Chlamydia trachomatis
  Adults and adolescents Azithromycin, 1 gm PO once or
Doxycycline, 100 mg PO 2 times/day × 7 days
 
  Children    
    <45 kg Erythromycin base/ethylsuccinate, 12.5 mg/kg PO 4 times/day × 14 days  
    ≥45 kg but <8 yr old Azithromycin, 1 gm PO once  
    ≥8 yr old Azithromycin, 1 gm PO once or
Doxycycline, 100 mg PO 2 times/day × 7 days
 
  Pregnant women Azithromycin, 1 gm PO once or
Amoxicillin, 500 mg PO 3 times/day × 7 days
 
  Newborns: ophthalmia or  pneumonia Erythromycin base/ethylsuccinate, 12.5 mg/kg PO 4 times/day × 14 days  
 Lymphogranuloma venereum Doxycycline, 100 mg PO 2 times/day × 21 days  
Gonococcal Infections (Gonorrhea) Neisseria gonorrhoeae
  Urethritis, cervicitis, proctitis Ceftriaxone, 250 mg IM once, plus azithromycin, 1 gm PO once  
  Pharyngitis Ceftriaxone, 250 mg IM once, plus azithromycin, 1 gm PO once  
  Disseminated gonococcal  infection (DGI) in adults Ceftriaxone, 1 gm IM or IV every 24 hr  
  DGI with meningitis Ceftriaxone, 1–2 gm IV every 12 hr × 10–14 days  
  DGI with endocarditis Ceftriaxone, 1–2 gm IV every 12 hr × 28 days or more  
  Conjunctivitis Ceftriaxone, 1 gm IM once  
  Newborns    
    Ophthalmia Erythromycin 0.5% ophthalmic ointment or, if the ointment is not available, ceftriaxone, 25–50 mg/kg IM or IV once (max. 125 mg)  
    Disseminated infection or   scalp abscess Ceftriaxone, 25–50 mg/kg IM or IV once/day × 7 days or
Cefotaxime, 25 mg/kg IM or IV every 12 hr × 7 days
 
  Children    
    Arthritis, bacteremia Ceftriaxone, 50 mg/kg IM or IV (max. 1 gm) once daily × 7 days  
    Vulvovaginitis, cervicitis,   proctitis, pharyngitis,   urethritis If 45 kg or less, ceftriaxone 125 mg IM once; if more than 45 kg, same as adult  
Nongonococcal Urethritis   Chlamydia trachomatis, Ureaplasma urealyticum, Trichomonas vaginalis, Mycoplasma genitalium
  Acute infection Azithromycin, 1 gm PO once or
Doxycycline, 100 mg PO 2 times/day × 7 days
  Recurrent/persistent Metronidazole (2 gm PO once) or tinidazole (2 gm PO once), either one plus azithromycin (1 gm PO once) if the drug was not used for initial therapy
  Treatment resistant, Mycoplasma  genitalium suspected Moxifloxacin, 400 mg PO once daily × 7 days
Pelvic Inflammatory Disease   Neisseria gonorrhoeae, Chlamydia trachomatis, others
  Inpatients Cefoxitin (2 gm IV every 6 hr) or cefotetan (2 gm IV every 12 hr), either one plus doxycycline (100 mg IV or PO every 12 hr) for 14 days
  Outpatients Cefoxitin (2 gm IM once, boosted with probenecid 1 gm PO once) or ceftriaxone (250 mg IM once), either one plus doxycycline (100 mg PO 2 times/day × 14 days), with or without metronidazole (500 mg PO 2 times/day × 14 days)
Sexually Acquired Epididymitis Ceftriaxone (250 mg IM once) plus doxycycline (100 mg PO 2 times/day × 10 days) Chlamydia trachomatis, Neisseria gonorrhoeae
Syphilis   Treponema pallidum
  Primary syphilis, secondary  syphilis, and early latent  syphilis Adults: Benzathine penicillin G, 2.4 million units IM once
Children: Benzathine penicillin G, 50,000 units/kg IM once (up to a max. of 2.4 million units)
 
  Late latent syphilis or latent  syphilis of unknown duration Adults: Benzathine penicillin G, 2.4 million units IM once/wk for 3 wk
Children: Benzathine penicillin G, 50,000 units/kg IM once/wk for 3 wk (up to a max. of 7.2 million units)
 
  Tertiary syphilis Benzathine penicillin G, 2.4 million units IM once/wk for 3 wk (must rule out CNS involvement)  
  Neurosyphilis Aqueous crystalline penicillin G, 18–24 million units IV daily for 10–14 days, administered by continuous infusion or in separate doses of 3–4 million units each every 4 hr  
  Congenital syphilis Aqueous crystalline penicillin G, 50,000 units/kg IV every 12 hr for the first 7 days of life, followed by 50,000 units/kg every 8 hr for the next 3 days or
Procaine penicillin G, 50,000 units/kg IM once daily for 10 days or
Benzathine penicillin G, 50,000 units/kg IM once
 
Acquired Immunodeficiency Syndrome (AIDS) See Chapter 94 Human immunodeficiency virus
Bacterial Vaginosis   Gardnerella vaginalis, Mycoplasma hominis, various anaerobes
  Nonpregnant women Metronidazole, 500 mg PO 2 times/day × 7 days or
Metronidazole gel (0.75%), 1 full applicator (5 gm) intravaginally once/day × 5 days or
Clindamycin cream (2%), 1 full applicator (5 gm) intravaginally at bedtime × 7 days
  Pregnant women Metronidazole, 500 mg PO 2 times/day × 7 days or
Metronidazole, 250 mg PO 3 times/day × 7 days or
Clindamycin, 300 mg PO 2 times/day × 7 days
Trichomoniasis Metronidazole, 2 gm PO once or
Tinidazole, 2 gm PO once
Trichomonas vaginalis
Chancroid Azithromycin, 1 gm PO once or
Ceftriaxone, 250 mg IM once or
Ciprofloxacin, 500 mg PO 2 times/day × 3 days or
Erythromycin base, 500 mg PO 3 times/day × 7 days
Haemophilus ducreyi
Genital Herpes Simplex Virus Infections Herpes simplex virus
  First episode, genital herpes Acyclovir, 400 mg PO 3 times/day × 7–10 days (or longer) or
Acyclovir, 200 mg PO 5 times/day × 7–10 days (or longer) or
Famciclovir, 250 mg PO 3 times/day × 7–10 days (or longer) or
Valacyclovir, 1 gm PO 2 times/day × 7–10 days (or longer)
 
  First episode, proctitis,  stomatitis, or pharyngitis Acyclovir, 400 mg PO 5 times/day for 7–10 days (or longer)  
  Severe infection Acyclovir, 5–10 mg/kg IV every 8 hr for 2–7 days or until clinical improvement, then PO acyclovir to complete at least 10 days  
  Recurrent episodes Acyclovir, 800 mg PO 2 times/day × 5 days or
Acyclovir, 800 mg PO 3 times/day × 2 days or
Acyclovir, 400 mg PO 3 times/day × 5 days or
Famciclovir, 125 mg PO 2 times/day × 5 days or
Famciclovir, 1 gm 2 times/day × 1 day or
Famciclovir, 500 mg once, followed by 200 mg 2 times/day for 2 days or
Valacyclovir, 500 mg PO 2 times/day × 3 days or
Valacyclovir, 1 gm PO once/day × 5 days
 
  Daily suppressive therapy Acyclovir, 400 mg PO 2 times/day or
Famciclovir, 250 mg PO 2 times/day or
Valacyclovir, 500 mg PO once/day or
Valacyclovir, 1 gm PO once/day
 
  Neonatal herpes Acyclovir, 20 mg/kg IV every 8 hr × 14 days (for skin or mucous membrane infection) or × 21 days (for disseminated or CNS infection)  
Proctitis Ceftriaxone (250 mg IM once) plus doxycycline (100 mg PO 2 times/day × 7 days) Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema pallidum, herpes simplex virus
Venereal Warts See Chapter 105 Human papillomavirus


image


image

< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 24, 2016 | Posted by in NURSING | Comments Off on Drug therapy of sexually transmitted diseases

Full access? Get Clinical Tree

Get Clinical Tree app for offline access